bariatric surgery vs glp 1 Metabolic and GLP-1 agonists | Blog Bariatric Surgery or GLP-1's: Which

Its Just Not That Simple What You Need to Know About GLP-1 Medications By Christie Caggiani RDN/LDN, CEDS-C, CIEC Licensed Dietitian and Nutrition Therapist Information and opinions about the new weight-loss drugs are more common than cute cats on TikTok

Notably, nearly 50% of the retatrutide phase 2 obesity trial were men, which is higher than in phase 3 clinical trials with tirzepatide (32.5% in SURMOUNT-1 [27]) and semaglutide 2.4 mg (25.9% in STEP-1 [8])

Injection site does not significantly affect systemic side effects like nausea or diarrhea, because those are driven by the medication's action on GLP-1 receptors throughout the body, not by local absorption differences

2012;7:e31394

So they get scared because they think I'm going to regain my weight, but they don't

Crowding the pipeline shifts the battleground from efficacy to differentiation once several agents all clear 20% weight loss, the moat becomes real-world outcomes in specific subpopulations, not the molecule